positions available now

Tag Archives: Research

Sponsors struggle with Ministerial discretion

The 2017 Medicines Australia Strategic Agreement with the Australian Government extended the existing five-year anniversary statutory price reduction (SPR) of 5% for F1 medicines and introduced new SPRs for drugs that have been listed for ten years and fifteen years … Continue reading

Posted in Life Sciences Industry, Market Access, PBS | Tagged , , , | Comments Off on Sponsors struggle with Ministerial discretion

Top 5 – Health in the 2014 Budget

Health has featured strongly in the Abbott Government’s first budget, but not as expected… 1. No PBS Pricing Reforms The anticipated PBS pricing reforms were absent in last week’s budget despite the recommendations of the Commission of Audit for the … Continue reading

Posted in Federal Budget, Life Sciences Industry, PBS | Tagged , , , | Comments Off on Top 5 – Health in the 2014 Budget

PharmaDispatch: Commercial Eyes working on ‘Convergence’

Commercial Eyes’ new Clinical Development division features in today’s issue of PharmaDispatch, reproduced here with the permission of www.pharmadispatch.com.au Commercial Eyes working on ‘Convergence’ According to the head of Commercial Eyes’ recently launched Clinical Development division, Ric DeGaris, his focus … Continue reading

Posted in Clinical Development, Commercial Eyes, Life Sciences Industry | Tagged , | Comments Off on PharmaDispatch: Commercial Eyes working on ‘Convergence’
Copyright © 2014 Commercial Eyes